UnitedHealth Group (UNH)
380.64
-4.91 (-1.27%)
NYSE · Last Trade: May 10th, 8:51 AM EDT
Detailed Quote
Previous Close | 385.55 |
---|---|
Open | 385.67 |
Bid | 380.20 |
Ask | 380.40 |
Day's Range | 378.54 - 386.55 |
52 Week Range | 378.54 - 630.73 |
Volume | 8,381,546 |
Market Cap | 346.38B |
PE Ratio (TTM) | 15.94 |
EPS (TTM) | 23.9 |
Dividend & Yield | 8.400 (2.21%) |
1 Month Average Volume | 9,290,535 |
Chart
About UnitedHealth Group (UNH)
UnitedHealth Group is a leading diversified health and well-being company that provides a wide range of health care products and services. The company operates through two main segments: UnitedHealthcare, which offers health insurance and health services to individuals and businesses, and Optum, which delivers pharmacy care, health management, and technology solutions. UnitedHealth Group focuses on enhancing health care access, improving health outcomes, and optimizing costs through integrated care solutions and data-driven insights. With a commitment to innovation and quality, the company aims to help people live healthier lives while making the health care system work better for everyone. Read More
News & Press Releases
Via Benzinga · May 9, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · May 9, 2025
Via Benzinga · May 9, 2025
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning.
Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Via StockStory · May 9, 2025
Shareholders of UnitedHealth filed a class-action lawsuit on Wednesday accusing the company of misleading investors by concealing the negative business impacts that followed the December 2024 killing of UnitedHealthcare CEO Brian Thompson.
Via Benzinga · May 8, 2025
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against UnitedHealth Group Incorporated (“UnitedHealth” or “the Company”) (NYSE: UNH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By The Schall Law Firm · Via Business Wire · May 8, 2025
Via The Motley Fool · May 8, 2025
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of UnitedHealth Group Incorporated (NYSE: UNH) between December 3, 2024 and April 16, 2025, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for UnitedHealth investors under the federal securities laws.
By The Rosen Law Firm, P.A. · Via Business Wire · May 7, 2025
Two of the Dow's 30 constituents are ripe for the picking amid the heart of earnings season, while another artificial intelligence (AI)-inspired component is sending the wrong signals.
Via The Motley Fool · May 6, 2025
Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Via StockStory · May 6, 2025
Via Benzinga · May 2, 2025
Via Benzinga · May 1, 2025
Medical stocks are usually considered defensive. But have they been too hammered by regulatory changes to hold up this year?
Via Investor's Business Daily · May 1, 2025
Wall Street expects the insurer to post a 10% drop in Medicare Advantage membership for 2025 but higher premiums to support an earnings beat.
Via Stocktwits · April 30, 2025
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session.
Via Chartmill · April 29, 2025
UnitedHealth Group is the largest healthcare company in the U.S. by revenue.
Via Talk Markets · April 29, 2025
The worst performing large-cap stocks last week were Fiserv, Northrop Grumman, Erie Indemnity, T-Mobile, Watsco, Gold Fields, Aon, AngloGold Ashanti, Ryan Specialty, Tyler Technologies, Kimberly-Clark, and UnitedHealth Group.
Via Benzinga · April 27, 2025
Via Benzinga · April 24, 2025
VIRGINIA BEACH, Va. - April 28, 2025 - PRLog -- Schonfeld & Associates, a publisher of business information products for over 40 years, has released the 2025 edition of SG&A Benchmarks for the Finance, Insurance, Real Estate industry sector. The report is a convenient source of information for professional managers seeking benchmark information on Selling, General & Administrative spending by major public corporations within the sector. Metrics for public companies provide important insight for other firms within the sector. SG&A expenses are all the direct and indirect selling expenses and all general and administrative expenses. SG&A expenses are also called Operating Expenses. Frequently, SG&A to Sales ratios are used to judge efficiency of management spending.Benchmarks for SG&A spending are hard to find. Averages may be available but are generally too broad to be useful. Within SG&A Benchmarks, the sector summary charts provide side by side comparison of annual median values for each industry within the sector for 2021-2024 as well as a chart of 10%ile, median and 90%ile values of SG&A to Sales ratio for 2024 by industry to illustrate the range of values reported by firms within each industry. To account for SG&A spending practices varying by size of revenues, individual companies are grouped based on fiscal 2024 sales. The detailed tables for each of the individual industries are presented with the companies in three groups as defined by sales of less than $100 million, sales between $100 million and $1 billion, and sales of more than $1 billion. The information presented for each company includes: fiscal 2023 and fiscal 2024 SG&A as a percentage of sales, annual percentage growth rate in SG&A spending and in sales, total sales for fiscal 2024 and headquarters location. Comparing the growth rate of SG&A expenses and sales gives a snapshot of where the profitability of the firm may be heading.The Finance, Insurance and Real Estate sector reports SG&A spending information for over 1065 publicly traded companies in seven industries: Depository Institutions (including Bank of America, JPMorgan Chase, Citigroup, Wells Fargo), Non-depository Credit Institutions (including Fannie Mae, American Express, Discover Financial Services), Security & Commodity Brokers and Services (including Charles Schwab, Goldman Sachs, Morgan Stanley), Insurance Carriers (including Cigna Group, Berkshire Hathaway, UnitedHealth Group), Insurance Agents and Services (including Marsh & McLennan, Equitable Holdings, Aon), Real Estate (including eXp World Holdings, Cushman & Wakefield, Redfin, CBRE Group) and Holding and Other Investment Offices (including Equinix, Blackstone REIT, Prologis, Crown Castle).This report will benefit anyone seeking competitive benchmark intelligence including corporate staff, financial analysts, investment professionals, lenders, M&A advisors, appraisers and industry consultants.Visit https://saibooks.com/product/sga-benchmarks-finance/ for more information and to place a secure order for immediate download.
Via PRLog · April 28, 2025